Moderna, Inc.: Moderna Announces Bivalent Booster mRNA-1273.214 Demonstrates Potent Neutralizing Antibody Response Against Omicron Subvariants BA.4 And BA.5
MRNA-1273.214 Exhibited a Greater Than 5-Fold Boost in Neutralizing Antibodies Against BA.4 and BA.5 Subvariants in Phase 2/3 StudyData Being Submitted to Regulators and for Peer Reviewed PublicationCAMBRIDGE
United Kingdom Lavina Talukdar Chris Ridley Exchange Commission Corporate Communications Head Of Media Moderna Inc
Source: finanznachrichten.de